Tg Therapeutics (TGTX) Inventory (2023 - 2026)

Tg Therapeutics' Inventory history runs 4 years deep, the most recent figure standing at $129.0 million for Q1 2026.

• On a quarterly basis, Inventory fell 18.21% year-over-year to $129.0 million in Q1 2026; TTM through Mar 2026 was $129.0 million, a 18.21% decrease from a year earlier, with the FY2025 full-year figure at $125.6 million, up 13.7% from the prior year.
• Inventory grew to $129.0 million in Q1 2026 per TGTX's latest filing, from $125.6 million in the prior quarter.
• Across five years, Inventory topped out at $157.8 million in Q1 2025 and bottomed at $27.2 million in Q1 2023.
• The 4-year median for Inventory is $84.7 million (2024), against an average of $92.3 million.
• Across the five-year window, Inventory jumped 185.51% in 2024 and slipped 18.21% in 2026, its largest moves.
• Year by year, Inventory stood at $39.8 million in 2023, then surged by 177.37% to $110.5 million in 2024, then increased by 13.7% to $125.6 million in 2025, then gained by 2.74% to $129.0 million in 2026.
• Per Business Quant, the three latest TGTX Inventory figures stand at $129.0 million (Q1 2026), $125.6 million (Q4 2025), and $147.0 million (Q3 2025).